DeWayne M. Pursley MD, MPH*

Department of Neonatology Chief
NICU Director
Beth Israel Deaconess Medical Center
Boston, MA

DeWayne Pursley MD, MPH, is chief of the Department of Neonatology and director of the Klarman Family Neonatal Intensive Care Unit (NICU) at Beth Israel Deaconess Medical Center (BIDMC). He is an Associate Professor of Pediatrics at Harvard Medical School (HMS) and a member of the Division of Newborn Medicine at Boston Children’s Hospital (BCH).

Dr. Pursley has led the “Choosing Wisely in Neonatology” research team, identifying opportunities to improve the overuse of antibiotics in the NICU. They report that the routine continuation of antibiotics beyond 48 hours for asymptomatic infants without evidence of bacterial infection as one of the “top five” targets for improvement in the Choosing Wisely Campaign.

Dr. Pursley is a graduate of Stanford University, HMS, and the Harvard School of Public Health. He trained in Pediatrics at BCH, remaining for a fourth year as chief medical resident, and then completed a fellowship in Neonatal-Perinatal Medicine at BIDMC, Brigham and Women’s Hospital, and BCH. Recently elected to the American Pediatric Society, his interests include NICU quality improvement, resource allocation and utilization, and racial and social disparities in infant outcomes. He is currently leading a project with the American Academy of Pediatrics (AAP) Perinatal Section to examine resource overuse in newborn medicine.

Dr. Pursley is chair-elect of the Neonatal-Perinatal Medicine Sub-board of the American Board of Pediatrics, and a member of the board of directors of the National Perinatal Information Center and the governing council of the American Hospital Association Section on Maternal-Child Health. He is past chair of the Executive Committee of the AAP Perinatal Section- where he focused his efforts on education, advocacy, and policy for neonatal care- and currently serves as vice president of the AAP Massachusetts chapter where he is committed more broadly to the health of all children in the Commonwealth. He is also the AAP liaison to the National Fetal and Infant Mortality Review Program and has served as a member of the expert panel to identify drug priorities as part of the federal government’s Best Pharmaceuticals for Children Act. He is a permanent member of the NIH National Institute of Child Health and Human Development (NICHD) Pediatrics Subcommittee study section.

Dr. Pursley recently served as a contributor to the NICHD “Disparities in Perinatal Medicine: Focus on Infant Mortality, Stillbirth and Preterm Birth” workshop; served on the Centers for Disease Control (CDC) Newborn Issues workgroup of the pandemic influenza workshop for pregnant women and newborns; provided testimony to the Food and Drug Administration on the effect of critical drug shortages on children and the need for improved neonatal drug investigation; and was a member of the NIH Consensus Panel on Inhaled Nitric Oxide for Premature Infants.

A recipient of the HMS Dean’s Community Service Award, Dr. Pursley has also been recognized with the March of Dimes Massachusetts Chapter Franklin Delano Roosevelt Award, the Excellence in Mentoring Award from the HMS Office of Recruitment and Multicultural Affairs, and the HMS Harold Amos Faculty Diversity Award.

* Steering Committee

back to main page